30.04.2021
A key international clinical study successfully demonstrated that with Abionic’s abioScope Sepsis can be diagnosed up to 72 hours earlier compared with current standard-of-care. The early recognition and management of sepsis improves outcomes. The results open new perspectives for more successful treatments against a condition claiming more lives than prostate cancer, breast cancer and AIDS combined.